검색
NovaBay Pharmaceuticals Inc
NBY관심 목록에 추가
1.950USD
0.0000.00%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
68.61M시가총액
손실P/E TTM
자세한 내용은 NovaBay Pharmaceuticals Inc 회사
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NovaBay Pharmaceuticals Inc 정보
종목 코드 NBY
회사 이름NovaBay Pharmaceuticals Inc
상장일Oct 26, 2007
CEOKazley (Michael John)
직원 수14
유형Ordinary Share
회계 연도 종료Oct 26
주소2000 Powell St Ste 1150
도시EMERYVILLE
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가United States of America
우편 번호94608-1804
전화15108998800
웹사이트https://novabay.com/
종목 코드 NBY
상장일Oct 26, 2007
CEOKazley (Michael John)
NovaBay Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
자주 묻는 질문
NovaBay Pharmaceuticals Inc의 상위 5대 주주는 누구인가요?
NovaBay Pharmaceuticals Inc의 상위 5대 주주는 다음과 같습니다: Ms. Swan Sit
NovaBay Pharmaceuticals Inc(NBY)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, NovaBay Pharmaceuticals Inc의 주식을 보유한 기관은 총 47곳이며, 이들이 보유한 주식의 총 가치는 약 1.80M로 전체 발행 주식의 6.77%를 차지합니다. 이는 2025Q4 대비 1464094.00 증가한 수치입니다.